SEC Form 4 · accession 0001127602-16-039358
ARIAD PHARMACEUTICALS INC · ARIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alexander J Denner
Director
Period of report
Feb 1, 2016
Accepted (ET)
Feb 3, 2016 · 5:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 1, 2016 | A | 12,500 | $0.00 | A | 35,165 | D | |
| Common Stock | holding | — | — | — | 7,798,665 | I | Sarissa Capital Domestic Fund LP | |
| Common Stock | holding | — | — | — | 5,051,335 | I | Sarissa Capital Offshore Master Fund LP |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | — | Feb 1, 2016 | A | 25,000 | A | — | — | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1The stock options vest as to one-fourth of the options on each of March 31, 2016, June 30, 2016, September 30, 2016, and December 31, 2016.